224 related articles for article (PubMed ID: 29675452)
1. Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.
Garber JJ; Mallick EM; Scanlon KM; Turner JR; Donnenberg MS; Leong JM; Snapper SB
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):273-288. PubMed ID: 29675452
[TBL] [Abstract][Full Text] [Related]
2. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
[TBL] [Abstract][Full Text] [Related]
3. Enteropathogenic
Tapia R; Kralicek SE; Hecht GA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
[TBL] [Abstract][Full Text] [Related]
4. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
[TBL] [Abstract][Full Text] [Related]
5. Clever Cooperation: Interactions Between EspF and Host Proteins.
Hua Y; Yan K; Wan C
Front Microbiol; 2018; 9():2831. PubMed ID: 30524410
[TBL] [Abstract][Full Text] [Related]
6. Tight junctions and enteropathogenic E. coli.
Weflen AW; Alto NM; Hecht GA
Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
[TBL] [Abstract][Full Text] [Related]
7. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
[TBL] [Abstract][Full Text] [Related]
8. Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation.
Vingadassalom D; Campellone KG; Brady MJ; Skehan B; Battle SE; Robbins D; Kapoor A; Hecht G; Snapper SB; Leong JM
PLoS Pathog; 2010 Aug; 6(8):e1001056. PubMed ID: 20808845
[TBL] [Abstract][Full Text] [Related]
9. Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly.
Campellone KG; Cheng HC; Robbins D; Siripala AD; McGhie EJ; Hayward RD; Welch MD; Rosen MK; Koronakis V; Leong JM
PLoS Pathog; 2008 Oct; 4(10):e1000191. PubMed ID: 18974829
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo.
Crepin VF; Girard F; Schüller S; Phillips AD; Mousnier A; Frankel G
Mol Microbiol; 2010 Jan; 75(2):308-23. PubMed ID: 19889090
[TBL] [Abstract][Full Text] [Related]
11. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
Tapia R; Kralicek SE; Hecht GA
Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
[TBL] [Abstract][Full Text] [Related]
13. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
[TBL] [Abstract][Full Text] [Related]
14. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways.
Alto NM; Weflen AW; Rardin MJ; Yarar D; Lazar CS; Tonikian R; Koller A; Taylor SS; Boone C; Sidhu SS; Schmid SL; Hecht GA; Dixon JE
J Cell Biol; 2007 Sep; 178(7):1265-78. PubMed ID: 17893247
[TBL] [Abstract][Full Text] [Related]
15. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.
Schüller S; Chong Y; Lewin J; Kenny B; Frankel G; Phillips AD
Cell Microbiol; 2007 May; 9(5):1352-64. PubMed ID: 17474908
[TBL] [Abstract][Full Text] [Related]
16. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.
Weflen AW; Alto NM; Viswanathan VK; Hecht G
Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948
[TBL] [Abstract][Full Text] [Related]
17. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
Ugalde-Silva P; Navarro-Garcia F
Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
[TBL] [Abstract][Full Text] [Related]
18. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
[TBL] [Abstract][Full Text] [Related]
19. Attaching and effacing pathogen-induced tight junction disruption in vivo.
Guttman JA; Li Y; Wickham ME; Deng W; Vogl AW; Finlay BB
Cell Microbiol; 2006 Apr; 8(4):634-45. PubMed ID: 16548889
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.
Tahoun A; Siszler G; Spears K; McAteer S; Tree J; Paxton E; Gillespie TL; Martinez-Argudo I; Jepson MA; Shaw DJ; Koegl M; Haas J; Gally DL; Mahajan A
Infect Immun; 2011 Nov; 79(11):4716-29. PubMed ID: 21875965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
